Novel cross-talk between three cardiovascular regulators: Thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release

Molecular Biology of the Cell

Volumn 19, Issue 11, 2008, Pages 4863-4874

  Duarte, Maria ^a,c   Kolev, Vihren ^a,d   Kacer, Doreen ^a   Mouta Bellum, Carla ^a   Soldi, Raffaella ^a,e   Graziani, Irene ^a,f   Kirov, Aleksandr ^a   Friesel, Robert ^a   Liaw, Lucy ^b   Small, Deena ^b   Verdi, Joseph ^a   Maciag, Thomas ^a   Prudovsky, Igor ^a,c  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF NEW HAMPSHIRE   (United States)

^c Alentejo Biotechnology Center (CEBAL)   (Portugal)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CBF1 PROTEIN; CELL PROTEIN; FIBROBLAST GROWTH FACTOR 1; JAGGED1; LAG 1 PROTEIN; NOTCH1 RECEPTOR; PAR1 PROTEIN; SUPPRESSOR OF HAIRLESS PROTEIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CARDIOVASCULAR AGENT; FIBROBLAST GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; NOTCH RECEPTOR; PEPTIDE FRAGMENT; PROTEINASE ACTIVATED RECEPTOR 1; SERRATE PROTEINS; SIGNAL PEPTIDE; THROMBIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; MULTIPOTENT STEM CELL; NEURAL CREST CELL; NEURAL STEM CELL; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TRANSPORT; REGULATORY MECHANISM; ANIMAL; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR WEIGHT; NEURAL CREST; PROTEIN TERTIARY STRUCTURE; SECRETION; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR AGENTS; CELL LINE; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR WEIGHT; MULTIPOTENT STEM CELLS; NEURAL CREST; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTOR, PAR-1; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, NOTCH; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; THROMBIN; TRANSCRIPTION, GENETIC;

EID: 58149316624     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-12-1237     Document Type: Article

References (60)

1. Aho, S. (2004). Soluble form of Jagged 1, unique product of epithelial kera-tinocytes and a regulator of keratinocyte differentiation. J. Cell Biochem. 92, 1271-1281.
2. Bassus, S., Herkert, O., Kronemann, N., Gorlach, A., Bremerich, D., Kirchmaier, C. M., Busse, R., and Schini-Kerth, V. B. (2001). Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 21, 1550-1555.
3. Bergmeyer, H. U. (1965). Methods of enzymatic analysis, New York: Academic Press.
4. Buehler, A. et al. (2002). Angiogenesis-independent cardioprotection in FGF-1 transgenic mice. Cardiovasc. Res. 55, 768-777.
5. Cao, H., Dronadula, N., and Rao, G. N. (2006). Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 290, C172-C182.
6. Chalmers, C. J., Balmanno, K., Hadfield, K., Ley, R., and Cook, S. J. (2003). Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem. J. 375, 99-109.
7. Christofori, G., and Luef, S. (1997). Novel forms of acidic fibroblast growth factor-1 are constitutively exported by beta tumor cell lines independent from conventional secretion and apoptosis. Angiogenesis 1, 55-70.
8. Cucina, A., Borrelli, V., Lucarelli, M., Sterpetti, A. V., Cavallaro, A., Strom, R., Santoro-D'Angelo, L., and Scarpa, S. (2002). Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells. Cell Biochem. Funct. 20, 39-46.
9. Ding, L., Coombs, G. S., Strandberg, L., Navre, M., Corey, D. R., and Madison, E. L. (1995). Origins of the specificity of tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 92, 7627-7631.
10. Duarte, M., Kolev, V., Soldi, R., Kirov, A., Graziani, I., Oliveira, S. M., Kacer, D., Friesel, R., Maciag, T., and Prudovsky, I. (2006). Thrombin induces rapid PAR1-mediated non-classical FGF1 release. Biochem. Biophys. Res. Commun. 350, 604-609.
11. Erzurum, V. Z., Bian, J. F., Husak, V. A., Ellinger, J., Xue, L., Burgess, W. H., and Greisler, H. P. (2003). R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue. J. Vasc. Surg. 37, 1075-1081.
12. Fallon, J. F., Lopez, A., Ros, M. A., Savage, M. P., Olwin, B. B., and Simandl, B. K. (1994). FGF-2, apical ectodermal ridge growth signal for chick limb development. Science 264, 104-107.
13. Fenton, J. W., 2nd, Ofosu, F. A., Brezniak, D. V., and Hassouna, H. I. (1998). Thrombin and antithrombotics. Semin. Thromb. Hemost. 24, 87-91.
14. Friesel, R., and Maciag, T. (1999). Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 82, 748-754.
15. Gridley, T. (2007). Notch signaling in vascular development and physiology. Development 134, 2709-2718.
16. Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M. L. (1997). Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71, 1842-1849.
17. Herbert, J.M., Dupuy, E., Laplace, M.C., Zini, J.M., Bar Shavit, R., and Tobelem, G. (1994). Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem. J. 303, 227-231.
18. Hrabe de Angelis, M., McIntyre, J., 2nd, and Gossler, A. (1997). Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386, 717-721.
19. Hsieh, J. J., Henkel, T., Salmon, P., Robey, E., Peterson, M. G., and Hayward, S. D. (1996). Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol. Cell Biol. 16, 952-959.
20. Ikeuchi, T., and Sisodia, S. S. (2003). The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage. J. Biol. Chem. 278, 7751-7754.
21. Jackson, A., Friedman, S., Zhan, X., Engleka, K. A., Forough, R., and Maciag, T. (1992). Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 89, 10691-10695.
22. Jarriault, S., Brou, C., Logeat, F., Schroeter, E. H., Kopan, R., and Israel, A. (1995). Signalling downstream of activated mammalian Notch. Nature 377, 355-358.
23. Javerzat, S., Auguste, P., and Bikfalvi, A. (2002). The role of fibroblast growth factors in vascular development. Trends Mol. Med. 8, 483-489.
24. Joutel, A., and Tournier-Lasserve, E. (1998). Notch signalling pathway and human diseases. Semin. Cell Dev. Biol. 9, 619-625.
25. Kondoh, K., Sunadome, K., and Nishida, E. (2007). Notch signaling suppresses p38 MAPK activity via induction of MKP-1 in myogenesis. J. Biol. Chem. 282, 3058-3065.
26. LaVallee, T. M., Tarantini, F., Gamble, S., Carreira, C. M., Jackson, A., and Maciag, T. (1998). Synaptotagmin-1 is required for fibroblast growth factor-1 release. J. Biol. Chem. 273, 22217-22223.
27. LaVoie, M. J., and Selkoe, D. J. (2003). The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secre- tase and release signaling fragments. J. Biol. Chem. 278, 34427-34437.
28. Li, L. et al. (1997). Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16, 243-251.
29. Maciag, T., Hoover, G. A., and Weinstein, R. (1982). High and low molecular weight forms of endothelial cell growth factor. J. Biol. Chem. 257, 5333-5336.
30. Masuya, M. et al. (2002). The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors. Int. J. Hematol. 75, 269-276.
31. McKeehan, W. L., Wang, F., and Kan, M. (1998). The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 59, 135-176.
32. Morrison, S. J., White, P. M.,Zock, C., and Anderson, D. J. (1999). Prospective identification, isolation by flow cytometry, and in vivo self-renewal of mul-tipotent mammalian neural crest stem cells. Cell 96, 737-749.
33. Neilson, K. M., and Friesel, R. (1996). Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, trans-membrane, and kinase domains. J. Biol. Chem. 271, 25049-25057.
34. Nelson, B. R., Hartman, B. H., Georgi, S. A., Lan, M. S., and Reh, T. A. (2007). Transient inactivation of Notch signaling synchronizes differentiation of neural progenitor cells. Dev. Biol. 304, 479-498.
35. Nickel, W. (2005). Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614.
36. Nikopoulos, G. N., Duarte, M., Kubu, C. J., Bellum, S., Friesel, R., Maciag, T., Prudovsky, I., and Verdi, J. M. (2007). Soluble Jagged1 attenuates lateral inhibition, allowing for the clonal expansion of neural crest stem cells. Stem Cells 25, 3133-3142.
37. Okunieff, P., Fenton, B. M., Zhang, L., Kern, F. G., Wu, T., Greg, J. R., and Ding, I. (2003). Fibroblast growth factors (FGFS) increase breast tumor growth rate, metastases, blood flow, and oxygenation without significant change in vascular density. Adv. Exp. Med. Biol. 530, 593-601.
38. Ornitz, D. M., and Itoh, N. (2001). Fibroblast growth factors. Genome Biol. 2.
39. Paing, M. M., Stutts, A. B., Kohout, T. A., Lefkowitz, R. J., and Trejo, J. (2002). beta-Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation. J. Biol. Chem. 277, 1292-1300.
40. Prudovsky, I. et al. (2003). The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell Sci. 116, 4871-4881.
41. Prudovsky, I., Tarantini, F., Landriscina, M., Neivandt, D., Soldi, R., Kirov, A., Small, D., Kathir, K. M., Rajalingam, D., and Kumar, T. K. (2008). Secretion without Golgi. J. Cell Biochem. 103, 1327-1343.
42. Qi, H., Rand, M. D., Wu, X., Sestan, N., Wang, W., Rakic, P., Xu, T., and Artavanis-Tsakonas, S. (1999). Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 283, 91-94.
43. Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., and Artavanis-Tsakonas, S. (1991). Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 67, 687-699.
44. Rosengart, T. K., Johnson, W. V., Friesel, R., Clark, R., and Maciag, T. (1988). Heparin protects heparin-binding growth factor-I from proteolytic inactiva-tion in vitro. Biochem. Biophys. Res. Commun. 152, 432-440.
45. Scehnet,J. S.,Jiang,W.,Kumar,S. R.,Krasnoperov,V.,Trindade,A.,Benedito, R., Djokovic, D., Borges, C., Ley, E. J., Duarte, A., and Gill, P. S. (2007). Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 109, 4753-4760.
46. Schumacher, B., Pecher, P., von Specht, B. U., and Stegmann, T. (1998). Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97, 645-650.
47. Sellke, F. W., Li, J., Stamler, A., Lopez, J. J., Thomas, K. A., and Simons, M. (1996). Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120, 182-188.
48. Shimizu, K., Chiba, S., Kumano, K., Hosoya, N., Takahashi, T., Kanda, Y., Hamada, Y., Yazaki, Y., and Hirai, H. (1999). Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods. J. Biol. Chem. 274, 32961-32969.
49. Small, D., Kovalenko, D., Kacer, D., Liaw, L., Landriscina, M., Di Serio, C., Prudovsky, I., and Maciag, T. (2001). Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype. J. Biol. Chem. 276, 32022-32030.
50. Small, D. et al. (2003). Notch activation suppresses fibroblast growth factor-dependent cellular transformation. J. Biol. Chem. 278, 16405-16413.
51. Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., Luger, T. A., and Hollenberg, M. D. (2005). Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26, 1-43.
52. Trifonova, R., Small, D., Kacer, D., Kovalenko, D., Kolev, V., Mandinova, A., Soldi, R., Liaw, L., Prudovsky, I., and Maciag, T. (2004). The non-transmem-brane form of Delta1, but not of Jagged1, induces normal migratory behavior accompanied by fibroblast growth factor receptor 1-dependent transformation. J. Biol. Chem. 279, 13285-13288.
53. Vas, V., Szilágyi, L., Pálóczi, K., and Uher, F. (2004). Soluble Jagged-1 is able to inhibit the function of its multivalent form to induce hematopoietic stem cell self-renewal in a surrogate in vitro assay. J. Leukoc. Biol. 75, 714-720.
54. Vu, T. K., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
55. Wang, X., Romanic, A. M., Yue, T. L., Feuerstein, G. Z., and Ohlstein, E. H. (2000). Expression of interleukin-1beta, interleukin-1 receptor, and interleu-kin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. Biochem. Biophys. Res. Commun. 271, 138-143.
56. Wong, M. K., Prudovsky, I., Vary, C., Booth, C., Liaw, L., Mousa, S., Small, D., and Maciag, T. (2000). A non-transmembrane form of Jagged-1 regulates the formation of matrix-dependent chord-like structures. Biochem. Biophys. Res. Commun. 268, 853-859.
57. Woolley, P. V., Gollin, S. M., Riskalla, W., Finkelstein, S., Stefanik, D. F., Riskalla, L., Swaney, W. P., Weisenthal, L., and McKenna, R. J., Jr. (2000). Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes. Mol. Diagn. 5, 179-190.
58. Xue, Y., Gao, X., Lindsell, C. E., Norton, C. R., Chang, B., Hicks, C., Gendron-Maguire, M., Rand, E. B., Weinmaster, G., and Gridley, T. (1999). Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8, 723-730.
59. Zimrin, A. B., Pepper, M. S., McMahon, G. A., Nguyen, F., Montesano, R., and Maciag, T. (1996). An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J. Biol. Chem. 271, 32499-32502.
60. Zimrin, A. B., Villeponteau, B., and Maciag, T. (1995). Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem. Biophys. Res. Commun. 213, 630-638.